Orgenesis — Company Overview, News & Financial Data

Orgenesis (NASDAQ:ORGS) is a pioneering company focused on the development, manufacturing, and processing of cell and gene therapies. They aim to revolutionize personalized medicine with a unique Therapeutic Platform, offering a range of services including point-of-care cell therapy treatments. The company is at the forefront of providing innovative solutions that could potentially transform the treatment of a wide array of diseases. Key projects involve developing technologies that enable hospitals and healthcare systems to process and administer therapies onsite, dramatically changing the current centralized production model. Orgenesis is dedicated to making life-saving treatments more accessible and affordable, with the ultimate goal of improving patient outcomes worldwide.